Beatriz Vaquerizo

Showing 1-9 of 9 articles

Coronary interventions

A randomized comparison of the coronary vasomotor function and myocardial flow in patients treated with everolimus-eluting bioresorbable scaffolds and everolimus-eluting metallic stents.

Gomez-Lara J, Salvatella N, Romaguera R, Brugaletta S, Nato M, Roura G, Ferreiro JL, Teruel L, Gracida M, Sabaté M, Vaquerizo B, Cequier A, Gomez Hospital J, Leon V, Fuentes L, Ariza A, Millan R, Ortega-Paz L

June 18, 2019 | 10.4244/EIJ-D-18-01203

Other

Radiation protection measures and sex distribution in European interventional catheterization laboratories: Results from the EAPCI Women's survey

Manzo-Silberman S, Piccaluga E, Radu M, James S, Schüpke S, Vaquerizo B, Kunadian V, Capranzano P, Mehilli J, Buchanan G, Chieffo A, Mauri J

March 19, 2019 | 10.4244/EIJ-D-18-01044

Coronary interventions

Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusions

Fam J, Ojeda S, Garbo R, Latib A, La Manna A, Vaquerizo B, Boukhris M, Vlachojannis G, van Geuns R, Ezhumalai B, Kawamoto H, van der Sijde J, Felix C, Pan M, Serdoz R, Boccuzzi G, De Paolis M, Sardella G, Mancone M, Tamburino C, Smits P, Di Mario C, Seth A, Serra A, Colombo A, Serruys P, Galassi A, Zijlstra F, Van Mieghem N, Diletti R

June 20, 2017 | 10.4244/EIJ-D-16-00253

Coronary interventions

Motivations for and barriers to choosing an interventional cardiology career path: results from the EAPCI Women Committee worldwide survey

Capranzano P, Kunadian V, Mauri J, Petronio A, Salvatella N, Appelman Y, Gilard M, Mikhail G, Schüpke S, Radu M, Vaquerizo B, Presbitero P, Morice M, Mehilli J

May 16, 2016 | 10.4244/EIJY15M07_03

Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study

Vaquerizo B, Barros A, Pujadas S, Bajo E, Estrada D, Miranda-Guardiola F, Rigla J, Jimenez M, Cinca J, Serra A

September 22, 2015 | 10.4244/EIJY14M12_07

European expert consensus on rotational atherectomy

Barbato E, Carrié D, Dardas P, Fajadet J, Gaul G, Haude M, Khashaba A, Koch K, Meyer-Gessner M, Palazuelos J, Reczuch K, Ribichini F, Sharma SK, Sipotz J, Sjögren I, Suetsch G, Szabo G, Valdés Chávarri M, Vaquerizo B, Wijns W, Windecker S, De Belder A

May 19, 2015 | 10.4244/EIJV11I1A6

Failing transcatheter aortic valve treated by transcatheter aortic valve in transcatheter aortic valve (TAV-in-TAV) implantation: valve safety versus valve durability

Vaquerizo B, Martucci G, Buithieu J, de Varennes B, Lachapelle K, Piazza N

December 22, 2014 | 10.4244/EIJV10I8A169

Unprotected left main stenting in the real world: five-year outcomes of the French Left Main Taxus registry

Mylotte D, Meftout B, Moynagh A, Vaquerizo B, Darremont O, Silvestri M, Louvard Y, Leymarie J-L, Morice M, Lefèvre T, Garot P

December 28, 2012 | 10.4244/EIJV8I8A147

ACS and STEMI treatment: gender-related issues

Chieffo A, Buchanan G, Mauri F, Mehilli J, Vaquerizo B, Moynagh A, Mehran R, Morice M

August 25, 2012 | 10.4244/EIJV8SPA6

1

Latest news

"Shocktopics” with intravascular lithotripsy, bioprosthetic valve fracture, myocardial fibrosis in TAVI...

Reimaged models and angiograms showing CO March 17, 2020

New ahead of print: Infolding of self expanding valve during transcatheter aortic valve implantation

Nandhakumar Vasu et al

Bioresorbable scaffolds and STEMI: an ideal setting, but still vacant

Christian Spaulding

New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

February 14, 2020

Guidance Papers

Guidelines, consensus & position papers

Defining procedural MI - does it matter (spoiler alert - it does!)

This week’s JAA’s: QFR in severe AS & Infection control for TAVI

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke